94 related articles for article (PubMed ID: 9468080)
1. Vasomotility and nitric oxide bioactivity of the bridging segments of the left anterior descending coronary artery.
Shiode N; Kato M; Teragawa H; Yamada T; Hirao H; Nomura K; Sasaki N; Yamagata T; Matsuura H; Kajiyama G
Am J Cardiol; 1998 Feb; 81(3):341-3. PubMed ID: 9468080
[TBL] [Abstract][Full Text] [Related]
2. [Pathophysiology of coronary spasm].
Kugiyama K; Yasue H
Nihon Rinsho; 1998 Oct; 56(10):2483-7. PubMed ID: 9796306
[TBL] [Abstract][Full Text] [Related]
3. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers.
Kugiyama K; Yasue H; Ohgushi M; Motoyama T; Kawano H; Inobe Y; Hirashima O; Sugiyama S
J Am Coll Cardiol; 1996 Nov; 28(5):1161-7. PubMed ID: 8890810
[TBL] [Abstract][Full Text] [Related]
4. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin.
Okumura K; Yasue H; Matsuyama K; Ogawa H; Kugiyama K; Ishizaka H; Sumida H; Fujii H; Matsunaga T; Tsunoda R
J Am Coll Cardiol; 1996 Jan; 27(1):45-52. PubMed ID: 8522709
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function.
Nakamura S; Sugiyama S; Fujioka D; Kawabata K; Ogawa H; Kugiyama K
Circulation; 2003 Sep; 108(12):1425-7. PubMed ID: 12975258
[TBL] [Abstract][Full Text] [Related]
6. Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease.
Heitzer T; Ollmann I; Köke K; Meinertz T; Munzel T
Circulation; 2003 Aug; 108(5):536-41. PubMed ID: 12874186
[TBL] [Abstract][Full Text] [Related]
7. Variations of segmental endothelium-dependent and endothelium-independent vasomotor tone after cardiac transplantation (qualitative changes in endothelial function).
Weis M; Peter-Wolf W; Mazzilli N; Olbrich HG; Schacherer C; Wiemer J; Burger W; Hartmann A
Am Heart J; 1997 Aug; 134(2 Pt 1):306-15. PubMed ID: 9313612
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina.
Kugiyama K; Yasue H; Okumura K; Ogawa H; Fujimoto K; Nakao K; Yoshimura M; Motoyama T; Inobe Y; Kawano H
Circulation; 1996 Aug; 94(3):266-71. PubMed ID: 8759065
[TBL] [Abstract][Full Text] [Related]
9. Relation of preservation of nitric oxide-dependent coronary vasomotor function to plasma vitamin C concentrations in cardiac transplant recipients.
Fang JC; Kinlay S; Hikita H; Suh JH; Piana RN; Selwyn AP; Frei B; Morrow JD; Ganz P
Am J Cardiol; 2000 Aug; 86(4):460-2. PubMed ID: 10946045
[No Abstract] [Full Text] [Related]
10. A T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene and coronary arterial vasomotility.
Yoshimura M; Nakayama M; Shimasaki Y; Ogawa H; Kugiyama K; Nakamura S; Ito T; Mizuno Y; Harada E; Yasue H; Miyamoto Y; Saito Y; Nakao K
Am J Cardiol; 2000 Mar; 85(6):710-4. PubMed ID: 12000044
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease.
Fichtlscherer S; Dimmeler S; Breuer S; Busse R; Zeiher AM; Fleming I
Circulation; 2004 Jan; 109(2):178-83. PubMed ID: 14662709
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factor.
Katz SD; Krum H
Am J Cardiol; 2001 May; 87(9):1089-92. PubMed ID: 11348607
[TBL] [Abstract][Full Text] [Related]
13. Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine.
Caramori PR; Adelman AG; Azevedo ER; Newton GE; Parker AB; Parker JD
J Am Coll Cardiol; 1998 Dec; 32(7):1969-74. PubMed ID: 9857880
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nitric oxide synthesis during the cold pressor test in patients with coronary artery disease.
Tousoulis D; Davies G; Tentolouris C; Crake T; Toutouzas P
Am J Cardiol; 1997 Jun; 79(12):1676-9. PubMed ID: 9202363
[TBL] [Abstract][Full Text] [Related]
15. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.
Fukuda Y; Teragawa H; Matsuda K; Yamagata T; Matsuura H; Chayama K
Heart; 2002 Mar; 87(3):264-9. PubMed ID: 11847169
[TBL] [Abstract][Full Text] [Related]
16. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function.
Wilkinson IB; Hall IR; MacCallum H; Mackenzie IS; McEniery CM; van der Arend BJ; Shu YE; MacKay LS; Webb DJ; Cockcroft JR
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):147-52. PubMed ID: 11788475
[TBL] [Abstract][Full Text] [Related]
17. Exogenous hyaluronidase induces release of nitric oxide from the coronary endothelium.
Evora PR; Pearson PJ; Chua YL; Discigil B; Schaff HV
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):707-11. PubMed ID: 11003752
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus.
Heitzer T; Krohn K; Albers S; Meinertz T
Diabetologia; 2000 Nov; 43(11):1435-8. PubMed ID: 11126415
[TBL] [Abstract][Full Text] [Related]
19. Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men.
Nietlispach F; Julius B; Schindler R; Bernheim A; Binkert C; Kiowski W; Brunner-La Rocca HP
Hypertension; 2007 Jul; 50(1):82-8. PubMed ID: 17502494
[TBL] [Abstract][Full Text] [Related]
20. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
Chu A; Chambers DE; Lin CC; Kuehl WD; Palmer RM; Moncada S; Cobb FR
J Clin Invest; 1991 Jun; 87(6):1964-8. PubMed ID: 2040689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
